How to Recruit Physicians for Market Research (Without Wasting Your Budget)
Most healthcare market research projects don’t fail in the discussion guide or the survey instrument. They fail earlier — in recruitment. If the people you interview aren’t the physicians who actually make the decisions your study is about, the most elegant methodology in the world produces confident answers to the wrong question.
Recruiting physicians is genuinely hard. They are busy, skeptical of cold outreach, expensive to compensate, and — for the specialties most studies need — scarce. This guide covers what two decades of physician recruitment has taught us about doing it right: who to recruit, how to screen, what to pay, how to keep scheduled interviews from falling apart, and the compliance questions that catch teams by surprise.
Start with who, not how many
The first recruitment decision most teams get wrong is treating it as a volume problem. Twenty interviews with loosely qualified physicians are worth less than eight with exactly the right ones.
Before any outreach, define the respondent in operational terms:
- Specialty and sub-specialty. “Cardiologist” is rarely specific enough. An interventional cardiologist, an electrophysiologist, and a general cardiologist will give you three different answers about the same device.
- Procedure or prescription volume. A surgeon who performs your target procedure twice a year and one who performs it weekly are different respondents. Set a minimum volume threshold and screen for it.
- Practice setting. Academic medical center, community hospital, private practice, and ambulatory surgery center each shape purchasing influence, protocol adherence, and exposure to new technology.
- Decision role. For many products the economic buyer is not the clinical user. If reimbursement or formulary questions matter, you need payers, pharmacy directors, or department chiefs — not only prescribers.
Write these down as explicit inclusion criteria before recruitment begins. Every shortcut taken here compounds into noise in your findings.
Screen like you mean it
A screener is not a formality; it is the instrument that protects everything downstream. Three practices separate rigorous screening from box-checking:
Verify identity and credentials. NPI lookup, state license verification, and practice confirmation take minutes and eliminate the most damaging failure mode in physician research: the respondent who isn’t who they claim to be.
Screen for behavior, not self-description. Ask how many of the relevant procedures the physician performed in the last 90 days — not whether they “regularly” perform them. Ask which specific devices or agents they used most recently. Concrete, recent, verifiable questions defeat aspirational answers.
Watch for professional respondents. Every experienced recruiter knows the physician who has somehow qualified for a study every month for years. Panel fatigue and professional respondents are a quiet epidemic in healthcare research. Fresh recruitment, participation history checks, and de-duplication against prior studies keep your sample honest. We never reuse repeat participants across engagements for exactly this reason.
Pay fair-market honoraria — and understand what that means
Physicians’ time has a well-established market rate, and honoraria below it don’t save money; they select for the wrong respondents. Expect specialist rates for a 45–60 minute interview to run several hundred dollars, with rare sub-specialists and KOLs above that. Surveys price lower per minute but follow the same logic.
Two compliance points matter more than most teams realize:
Fair market value is a compliance concept, not just a budgeting one. Honoraria far above market rate can look like inducement, especially when the research sponsor is a manufacturer. Documented, consistent FMV rates protect everyone.
The Sunshine Act can apply. Payments to US physicians that are made by or on behalf of a manufacturer may be reportable under Open Payments. Whether a given study’s honoraria are reportable depends on how the research is structured — in particular, whether respondents and sponsor are double-blinded through an independent research firm. If your study touches this territory, resolve the reporting question before fieldwork, not after. (We wrote a full post on when double-blinding makes a difference.)
Run scheduling like an operations problem
Recruitment doesn’t end when a physician says yes. It ends when the interview has happened, the recording is on file, and the honorarium is paid. The mechanics in between are where response quality is silently won or lost:
- Confirm in writing immediately, with the date, time, duration, format, and honorarium stated plainly.
- Automate reminders — at minimum 24 hours and 1 hour before. Physician no-show rates drop sharply with disciplined reminders.
- Call the respondent; don’t make them dial in. Every step you remove from the physician’s side reduces attrition. We place the call at the scheduled time so the respondent never has to find a link or a dial-in code.
- Record and transcribe with consent. An interview that lives only in the moderator’s notes is half an interview.
- Pay promptly. Slow honorarium payment is the fastest way to poison a panel and your reputation with it. Same-cycle payment, with a thank-you, keeps the best respondents willing to work with you again.
- Hold a small overrecruit. Even with perfect operations, clinical schedules intervene. Recruiting 10–15% above target keeps a no-show from becoming a fieldwork extension.
Hard-to-reach specialties need different tactics
For primary care, general recruitment channels work. For pediatric electrophysiologists, transplant surgeons, or hospital pharmacy directors, they don’t — the population is too small and too shielded. What works instead:
- Relationship-based referral. KOLs and existing panel members can open doors that cold outreach cannot. A warm introduction from a respected colleague outperforms any email sequence.
- Conference and society targeting. Specialty societies concentrate exactly the physicians you need; recruitment timed around their meetings reaches people who ignore everything else.
- Longer lead times and realistic feasibility. If a recruiter promises you fifteen interviews with a sub-specialty that has a few hundred practitioners nationally, on two weeks’ notice, be skeptical. Honest feasibility numbers up front beat heroic promises followed by quiet quota reductions.
What good recruitment looks like in numbers
When you evaluate a recruitment effort — your own or a partner’s — the health indicators are consistent:
- Screen-out rate that isn’t suspiciously low. Rigorous screeners reject people. If nearly everyone qualifies, the screener isn’t screening.
- Show rates above 90% for scheduled interviews, sustained by the operational discipline above.
- Zero identity failures. Every respondent verified against NPI and license records.
- Fresh respondents. Participation history disclosed, professional respondents excluded.
- On-time fieldwork. Recruitment that finishes when it said it would, because feasibility was honest at the start.
Doing it yourself vs. using a partner
In-house recruitment can work for studies with generous timelines, common specialties, and staff who can absorb the operational load. The calculus changes when the specialty is rare, the timeline is short, decision-makers (payers, chiefs, directors) are in scope, or Sunshine Act questions require an independent, double-blinded structure between sponsor and respondents.
That last point is worth underlining: an independent research firm doesn’t just save effort — it changes what is structurally possible, from blinding to honest feasibility to a vetted network built over years rather than assembled per project.
If you’re weighing that decision for an upcoming study, talk to us. We’ll give you an honest feasibility read on your target respondents — including, when the honest answer is that your quota or timeline needs to change, telling you so before you’ve spent anything finding out the hard way.